Influence of St John's wort on catecholamine turnover and cardiovascular regulation in humans

Clinical Pharmacology and Therapeutics

Volumn 76, Issue 5, 2004, Pages 480-489

  Schroeder, Christoph ^a   Tank, Jens ^a   Goldstein, David S ^a   Stoeter, Michael ^a   Haertter, Sebastian ^a   Luft, Friedrich C ^a   Jordan, Jens ^a,b  

^a FRANZ VOLHARD CLINIC   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; CATECHOLAMINE; DESIPRAMINE; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; IMIPRAMINE; NORADRENALIN;

ADULT; ARTICLE; CARDIOVASCULAR REFLEX; CATECHOLAMINE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; FEMALE; HEAD TILTING; HEART RATE VARIABILITY; HEMODYNAMICS; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; NORADRENALIN UPTAKE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

3,4-DIHYDROXYPHENYLACETIC ACID; ADRENERGIC UPTAKE INHIBITORS; ADULT; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR PHYSIOLOGY; CATECHOLAMINES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERICUM; IMIPRAMINE; MALE; METHOXYHYDROXYPHENYLGLYCOL; NITRIC OXIDE DONORS; NITROPRUSSIDE; NOREPINEPHRINE; PERYLENE; POSTURE; SUPINE POSITION;

EID: 7944232374     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.08.005     Document Type: Article

References (38)

1. V. Butterweck Mechanism of action of St John's wort in depression: what is known? CNS Drugs 17 2003 539 562
2. E. Ernst The risk-benefit profile of commonly used herbal therapies: Ginkgo, St John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136 2002 42 53
3. A. Singer, M. Wonnemann, W.E. Muller Hyperforin, a major antidepressant constituent of St John's wort, inhibits serotonin uptake by elevating free intracellular Na+ J Pharmacol Exp Ther 290 1999 1363 1368
4. W.E. Muller, A. Singer, M. Wonnemann Hyperforin--antidepressant activity by a novel mechanism of action Pharmacopsychiatry 34 Suppl 1 2001 S98 102
5. G. Calapai, A. Crupi, F. Firenzuoli, G. Inferrera, F. Squadrito, A Parisi Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum Pharmacopsychiatry 34 2001 45 49
6. H.M. Thiede, A. Walper Inhibition of MAO and COMT by hypericum extracts and hypericin J Geriatr Psychiatry Neurol 7 Suppl 1 1994 S54 6
7. M. Gobbi, M. Moia, L. Pirona, P. Morizzoni, T. Mennini In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters Pharmacopsychiatry 34 Suppl 1 2001 S45 8
8. A. Denke, H. Schempp, D. Weiser, E.F. Elstner Biochemical activities of extracts from Hypericum perforatum L. 5th communication: dopamine-beta- hydroxylase-product quantification by HPLC and inhibition by hypericins and flavonoids Arzneimittelforschung 50 2000 415 419
9. E. Kleber, T. Obry, S. Hippeli, W. Schneider, E.F. Elstner Biochemical activities of extracts from Hypericum perforatum L. 1st Communication: inhibition of dopamine-beta-hydroxylase Arzneimittelforschung 49 1999 106 109
10. C. Schroeder, J. Tank, M. Boschmann, A. Diedrich, A.M. Sharma, I Biaggioni Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance Circulation 105 2002 347 353
11. A.L. Birkenfeld, C. Schroeder, M. Boschmann, J. Tank, G. Franke, F.C Luft Paradoxical effect of sibutramine on autonomic cardiovascular regulation Circulation 106 2002 2459 2465
12. M. Boschmann, C. Schroeder, N.J. Christensen, J. Tank, G. Krupp, I Biaggioni Norepinephrine transporter function and autonomic control of metabolism J Clin Endocrinol Metab 87 2002 5130 5137
13. J.R. Shannon, N.L. Flattem, J. Jordan, G. Jacob, B.K. Black, I Biaggioni Orthostatic intolerance and tachycardia associated with norepinephrine- transporter deficiency N Engl J Med 342 2000 541 549
14. N.D. Huebert, V. Schwach, C. Hinze, K.D. Haegele Selectivity of MDL 72,974A for MAO-B inhibition based on substrate and metabolite concentrations in plasma Prog Brain Res 106 1995 135 142
15. A. Illi, S. Sundberg, P. Ojala-Karlsson, M. Scheinin, A. Gordin Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers Clin Pharmacol Ther 59 1996 450 457
16. B. Friedgen, R. Wolfel, K.H. Graefe The contribution by monoamine oxidase and catechol-O-methyltransferase to the total-body and pulmonary plasma clearance of catecholamines Naunyn Schmiedebergs Arch Pharmacol 353 1996 193 199
17. J. Jordan, A. Lipp, J. Tank, C. Schroder, M. Stoffels, G Franke Catechol-o-methyltransferase and blood pressure in humans Circulation 106 2002 460 465
18. D. Robertson, M.R. Goldberg, J. Onrot, A.S. Hollister, R. Wiley, J.-G.J Thompson Isolated failure of autonomic noradrenergic neurotransmission Evidence for impaired beta-hydroxylation of dopamine N Engl J Med 314 1986 1494 1497
19. R. Mosqueda-Garcia Evaluation of autonomic failure D. Robertson I. Biaggioni Disorders of the autonomic nervous system 1995 Harwood Academic Publishers GmbH Luxembourg 25 59
20. J.R. Shannon, J. Jordan, B.K. Black, F. Costa, D. Robertson Uncoupling of the baroreflex by N(N)-cholinergic blockade in dissecting the components of cardiovascular regulation Hypertension 32 1998 101 107
21. A. Sherwood, M.T. Allen, J. Fahrenberg, R.M. Kelsey, W.R. Lovallo, L.J. van Doornen Methodological guidelines for impedance cardiography Psychophysiology 27 2002 1 23
22. Anonymous Heart rate variability: standards of measurement, physiological interpretation and clinical use Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Circulation 93 1996 1043 1065
23. J. Tank, J. Jordan, A. Diedrich, M. Stoffels, G. Franke, H.D Faulhaber Genetic influences on baroreflex function in normal twins Hypertension 37 2001 907 910
24. G. Bertinieri, M. Di Rienzo, A. Cavallazzi, A.U. Ferrari, A. Pedotti, G. Mancia A new approach to analysis of the arterial baroreflex J Hypertens Suppl 3 3 1985 S79 81
25. R. Kerb, J. Brockmoller, B. Staffeldt, M. Ploch, I. Roots Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin Antimicrob Agents Chemother 40 1996 2087 2093
26. S. Hartter, C. Hiemke Column switching and high-performance liquid chromatography in the analysis of amitriptyline, nortriptyline and hydroxylated metabolites in human plasma or serum J Chromatogr 578 1992 273 282
27. G. Eisenhofer, D.-S. Goldstein, R. Stull, H.-R. Keiser, T. Sunderland, D.-L Murphy Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase Clin Chem 32 1986 2030 2033
28. G. Preiss, C. Polosa Patterns of sympathetic neuron activity associated with Mayer waves Am J Physiol 226 1974 724 730
29. J. Tank, C. Schroeder, A. Diedrich, E. Szczech, S. Haertter, A.M Sharma Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition Circulation 107 2003 2949 2954
30. M.D. Esler, G. Wallin, P.K. Dorward, G. Eisenhofer, R. Westerman, I Meredith Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans Am J Physiol 260 4 Pt 2 1991 R817 23
31. G. Eisenhofer, T. Saigusa, M.D. Esler, H.S. Cox, J.A. Angus, P.K. Dorward Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits Am J Physiol 260 4 Pt 2 1991 R824 32
32. S. Sundberg, M. Scheinin, A. Illi, J. Akkila, A. Gordin, T. Keranen The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise Br J Clin Pharmacol 36 1993 451 456
33. S. Sundberg, M. Scheinin, P. Ojala-Karlsson, J. Akkila, A. Gordin The effects of the COMT inhibitor nitecapone for one week on exercise haemodynamics and catecholamine disposition Eur J Clin Pharmacol 44 1993 287 290
34. D.S. Goldstein, R.J. Polinsky, M. Garty, D. Robertson, R.T. Brown, I Biaggioni Patterns of plasma levels of catechols in neurogenic orthostatic hypotension Ann Neurol 26 1989 558 563
35. N. Serdarevic, G.P. Eckert, W.E. Muller The effects of extracts from St John's wort and Kava Kava on brain neurotransmitter levels in the mouse Pharmacopsychiatry 34 Suppl 1 2001 S134 6
36. M. Melzer, D. Fuhrken, R. Kolkmann Hyperforin im Johanniskraut Deutsche Apotheker Zeitung 138 2002 56 62
37. M. Wurglics, K. Westerhoff, A. Kaunzinger, A. Wilke, A. Baumeister, J Dressman Comparison of German St John's wort products according to hyperforin and total hypericin content J Am Pharm Assoc (Wash) 41 2001 560 566
38. M. Wurglics, K. Westerhoff, A. Kaunzinger, A. Wilke, A. Baumeister, J Dressman Batch-to-batch reproducibility of St John's wort preparations Pharmacopsychiatry 34 Suppl 1 2001 S152 6